Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-21 Purchase(A) | 2026-08-07 4:15 pm | OKYO Pharma Ltd | OKYO | JACOB GARY S CHIEF DEVELOPMENT OFFICER | 3,500 | $1.4 | $4,900 | 112,420 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-21 Option Award | 2026-07-23 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | JACOB GARY S CHIEF DEVELOPMENT OFFICER | 3,500 | $1.4 | 112,420 (Direct) | View |
Ownership | 2026-03-18 8:37 pm | N/A N/A | OKYO Pharma Ltd | OKYO | JACOB GARY S Chief Development Officer | 0 | $0 | 1,108,829 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 8:01 pm | 2024-02-19 2026-02-19 | Hepion Pharmaceuticals Inc. | HEPA | JACOB GARY S Director | 85,000 | $0 | 102,120 (Direct) | View |
Ownership | 2022-05-16 5:44 pm | N/A 2029-01-06 | OKYO Pharma Ltd | OKYO | JACOB GARY S Chief Executive Officer | 0 | $0 | 53,000,000 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-05 5:18 pm | 2023-01-01 2032-01-01 | Virpax Pharmaceuticals Inc. | VRPX | JACOB GARY S Director | 12,091 | $0 | 12,091 (Direct) | View |